Searchable abstracts of presentations at key conferences in endocrinology

ea0035p500 | Diabetes therapy | ECE2014

Liraglutide effects on glycaemic control, body weight, blood pressure and lipid profile in obese patients with type 2 diabetes: real-life clinical practice

Fernandez-Garcia Jose Carlos , Mancha-Doblas Isabel , Cortes-Salazar Carmen Maria , Picon-Cesar Maria Jose , Gomez-Perez Ana Maria , Roca Mar , Tinahones Francisco

Objective: To evaluate the efficacy of liraglutide, a new glucagon-like peptide 1 analogue, on glycaemic control, body weight, blood pressure and lipid profile in obese patients with type 2 diabetes mellitus (T2DM).Material and methods: Patients attending a tertiary Endocrinology Unit who were prescribed liraglutide (January 2013–December 2013) and assessed both at baseline and first post-initiation visit were included in the analysis. The primary e...

ea0035p597 | Endocrine tumours and neoplasia | ECE2014

Everolimus in monotherapy as a therapeutic option in paragangliomas/pheochromocytomas

Cuadro Alberto Torres , Rodriguez Jose Perez , Tamarit Ana Albero , Hernandez Tomas Martin , Rivera Natividad Gonzalez , Zoilo Juan Jose Reina , Carrasco Fernando Henao , Merino Luis De La Cruz

Introduction: Everolimus is a drug selective inhibitor of mTOR. In 2012 a Phase 2 study* of everolimus monotherapy demonstrated modest efficacy in patients with pheochromocytomas/paragangliomas. Our objective was to evaluate the efficacy and safety of everolimus in a patient with paraganglioma. (*Phase 2 study of everolimus monotherapy in patient with nonfunctioning neuroendocrine tumor or pheochromocytomas/paraglangliomas. Do-Young Oh et al. Cancer 2012 <str...

ea0070aep1048 | Hot topics (including COVID-19) | ECE2020

Diabetes and COVID-19

Miguel Peteiro Miranda Carlos , Jorge Ortez Toro Jose , Sanz Martín Borja , Román Gimeno Sergio , Urdaiz Borque Rosana , Tabuenca Ana Agudo , Gimeno Orna Jose Antonio

Background: Although obesity and has been associated with COVID-19 mortality, the absolute and relative risks for Type 2 diabetes (DM2) is unknown. The aim of this study was to analyse metabolic characteristics of patients infected by COVID-19 hospitalised and evaluate whether DM2 have an impact in this group of patients.Methods: We retrospectively analysed data of COVID-19 patients hospitalized to a large academic hospital system in Zaragoza between Mar...

ea0032oc1.1 | Pituitary &amp; Molecular Endocrinology | ECE2013

The consequences of changing endogenous GH/IGF1 levels on carcinogen-induced mammary gland tumorigenesis are dependent on metabolic status in mice

Gahete Manuel D , Cordoba-Chacon Jose , Lantvit Daniel D , Perez-Jiminez Francisco , Lopez-Miranda Jose , Swanson Steven M , Castano Justo P , Luque Raul M , Kineman Rhonda D

ESE Young Investigator AwardIntroduction: GH and IGF1 are thought to promote breast carcinogenesis as circulating levels of GH/IGF1 are positively correlated with breast cancer risk in epidemiologic studies, and mouse models with developmental GH/IGF1 deficiency or resistance are less susceptible to breast cancer development. However, no studies have shown that high levels of circulating GH/IGF1 can promote mammary tumorigenesis. In this...

ea0022p136 | Cardiovascular endocrinology and lipid metabolism | ECE2010

Serum ferritin and risk of the metabolic syndrome in cross-sex hormone-treated transsexuals

Fernandez Antonio Becerra , Lopez Gilberto Perez , Menacho Miriam , Lucio Perez Maria Jesus , Araque Nuria Asenjo , Rodriguez Molina Jose Miguel , Llopis Agelan Jose Luis

Moderately elevated body iron stores may be associated with several components of the metabolic syndrome (MetSyn). Elevated serum ferritin levels (Fer) independently predicted incident type 2 diabetes in prospective studies in apparently healthy men and women.Aims: To analyze the association between Fer and components of MetSyn in transsexuals before and after 2-year cross-sex treatment (CST).Methods: Before starting the CST in 90 ...

ea0022p474 | Female reproduction | ECE2010

Serum ferritin in female-to-male transsexuals with polycystic ovary syndrome

Lopez Gilberto Perez , Fernandez Antonio Becerra , Menacho Miriam , Perez Maria Jesus Lucio , Araque Nuria Asenjo , Molina Jose Miguel Rodriguez , Agelan Jose Luis Llopis

Elevated serum ferritin levels has been reported in premenopausal women presenting polycystic ovary syndrome (PCOS) and hyperandrogenism, and thus may be involved in the development of insulin resistance, type 2 diabetes y cardiovascular disease. In female-to-male transsexuals (FMTs) PCOS is frequent and this issue has been little studied.Aims: To study the serum ferritin in FMTs with PCOS and their relations with markers of insulin resistance (IR) and m...

ea0022p675 | Obesity | ECE2010

Relationship between obesity and classic cardiovascular risk factors

Gomez-Barrado Jose Javier , Polo Jose , Gomez-Martino Juan Ramon , Barquilla Alfonso , Vega Jorge , Turegano Soledad , Gallego Rocio , Garciperez de Vargas Francisco Javier

Obesity is a disease very prevalent and often associated with morbidities and cardiovascular risk factors. We explore the relationship between the presence of obesity with cardiovascular risk factors more frequent and the presence of cardiovascular disease (CVD) after (ischemic heart disease, cerebrovascular disease, peripheral artery).Material and methods: A sample of 1491 individuals of both sexes, over 14 years, elected by random sampling three of the...

ea0022p689 | Obesity | ECE2010

Influence of age of onset of metabolic syndrome

Gomez-Barrado Jose Javier , Gomez-Martino Juan Ramon , Polo Jose , Barquilla Alfonso , Turegano Soledad , Vega Jorge , de Vargas Francisco Javier Garciperez , Mendoza Javier

The metabolic syndrome (MS) is a pathological entity that carries a high cardiovascular risk, and whose risk factors may occur at an early age. No data are available in our area on the influence of age on the prevalence of MS.Objectives: To determine the prevalence of MS in our area, by age group and compare the frequency of occurrence of MS in young adults (<40 years) (J) and mature adults (>40 years) (M).Methods: Observat...

ea0020p92 | Thyroid | ECE2009

Autoimmune thyroiditis, Graves’ disease and cardiovascular risk factors

Neves Celestino , Alves Marta , Pereira Luis Miguel , Carvalho Ema , Pimentel Isolina , Carvalho Renata , Guimaraes Cristina , Ramos Joao Pedro , Carvalho Davide , Delgado Jose Luis , Medina Jose Luis

Aims: To examine whether treated autoimmune thyroiditis (AIT) and GravesÂ’ disease (GD) are associated with increased cardiovascular risk factors.Patients and methods: We analysed the levels of total cholesterol (TC), HDL, LDL, triglycerides (TG), ApoB, ApoA1, Lp[a], homocysteine, CRP, folic acid and vitamin B12 in 50 patients with GD and in 130 patients with AIT, after normalization of thyroid function. Patients with GD were treated with propylthiou...

ea0020p132 | Thyroid | ECE2009

Thyroid function, serum lipids and insulin resistance in patients with autoimmune thyroiditis

Neves Celestino , Alves Marta , Pereira Luis Miguel , Pimentel Isolina , Carvalho Ema , Carvalho Renata , Guimaraes Cristina , Ramos Joao Pedro , Carvalho Davide , Delgado Jose Luis , Medina Jose Luis

Objective: The aim of this study was to examine the hypothesis that thyroid function, in euthyroid subjects with autoimmune thyroiditis (AIT), is associated with insulin resistance, serum lipid concentrations, and other cardiovascular (CV) risk factors. Subjects and Methods: We recorded thyroid function tests, BMI, insulin resistance markers comprising the Homeostasis Model Assessment for insulin resistance (HOMA-IR), the Quantitative Insulin Sensitivity Check Index (QUICKI), ...